Cargando…

COVID-19 vaccine safety and efficacy in patients with immune-mediated inflammatory disease: Review of available evidence

Dermatologists diagnose and treat many immune-mediated inflammatory diseases (IMID). Understanding the inherent immune dysregulation of these diseases as well as the additional disruption that comes as a result of IMID treatments has been important during the COVID-19 pandemic. With vaccines becomin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wack, Sarah, Patton, Timothy, Ferris, Laura K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier on behalf of the American Academy of Dermatology, Inc. 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336973/ https://www.ncbi.nlm.nih.gov/pubmed/34363909 http://dx.doi.org/10.1016/j.jaad.2021.07.054

Ejemplares similares

A focused review on technologies, mechanisms, safety, and efficacy of available COVID-19 vaccines
por: Ghasemiyeh, Parisa, et al.
Publicado: (2021)

Booster COVID-19 Vaccines for Immune-Mediated Inflammatory Disease Patients: A Systematic Review and Meta-Analysis of Efficacy and Safety
por: Lee, Ainsley Ryan Yan Bin, et al.
Publicado: (2022)

COVID-19 Vaccines and the Efficacy of Currently Available Vaccines Against COVID-19 Variants
por: Panneer Selvam, Suganya, et al.
Publicado: (2022)

Effectiveness of COVID-19 vaccination in immune-mediated inflammatory diseases
por: Sparks, Jeffrey A, et al.
Publicado: (2022)

Maternal COVID-19, vaccination safety in pregnancy, and evidence of protective immunity
por: Pham, Amelie, et al.
Publicado: (2021)

Efficacy and safety of COVID‐19 vaccines
por: Graña, Carolina, et al.
Publicado: (2022)

The effects of methotrexate on the immune responses to the COVID-19 vaccines in the patients with immune-mediated inflammatory disease: A systematic review of clinical evidence
por: Al-Haideri, Maysoon T., et al.
Publicado: (2023)

The Benefits of Vaccinating With the First Available COVID-19 Coronavirus Vaccine
por: Bartsch, Sarah M., et al.
Publicado: (2021)

Prospects for rotavirus vaccine introduction in the Philippines: Bridging the available evidence into immunization policy
por: Lopez, Anna Lena, et al.
Publicado: (2019)

No safety signal after COVID-19 vaccination for immune-mediated neurological events
Publicado: (2022)

Efficacy and Safety of COVID-19 Vaccines—An Update
por: Sharma, Eshani, et al.
Publicado: (2022)

COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases
por: Boekel, Laura, et al.
Publicado: (2022)

Limited available evidence supports theoretical predictions of reduced vaccine efficacy at higher exposure dose
por: Langwig, Kate E., et al.
Publicado: (2019)

Susceptibility to COVID-19 and Immunologic Response to Vaccination in Patients With Immune-Mediated Inflammatory Diseases
por: Finckh, Axel, et al.
Publicado: (2023)

Vaccinations in patients with immune-mediated inflammatory diseases
por: Rahier, Jean-François, et al.
Publicado: (2010)

Methodological frontiers in vaccine safety: qualifying available evidence for rare events, use of distributed data networks to monitor vaccine safety issues, and monitoring the safety of pregnancy interventions
por: Dodd, Caitlin, et al.
Publicado: (2021)

Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus
por: Kash, Natalie, et al.
Publicado: (2015)

Ensuring vaccine potency and availability: how evidence shaped Gavi's Immunization Supply Chain Strategy
por: Prosser, Wendy, et al.
Publicado: (2022)

Vaccination card availability and childhood immunization in Senegal
por: Seror, Valérie, et al.
Publicado: (2020)

Post-vaccination COVID-19 deaths: a review of available evidence and recommendations for the global population
por: Lamptey, Emmanuel
Publicado: (2021)

Safety and Efficacy of the Common Vaccines against COVID-19
por: Liu, Ying, et al.
Publicado: (2022)

Efficacy and safety of COVID-19 vaccination in patients with cirrhosis
por: Ivashkin, Vladimir, et al.
Publicado: (2022)

Immunogenicity and safety of mixed COVID-19 vaccine regimens in patients with immune-mediated inflammatory diseases: a single-centre prospective cohort study
por: Hitchon, Carol A, et al.
Publicado: (2023)

Vitamins, supplements and COVID-19: a review of currently available evidence
por: Speakman, Lauren L, et al.
Publicado: (2021)

COVID-19 vaccine confidence in the post-vaccination era: Perceptions among adults with immune-mediated inflammatory diseases
por: Santana, F.M., et al.
Publicado: (2023)

Available evidence and potential for vaccines for reduction in antibiotic prescriptions
por: Gabutti, Giovanni
Publicado: (2022)

Evaluation of the Safety and Efficacy of Hand Sanitizer Products Marketed to Children Available during the COVID-19 Pandemic
por: Gloekler, Lauren E., et al.
Publicado: (2022)

Accelerated waning of immune responses to a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases
por: Mrak, Daniel, et al.
Publicado: (2023)

COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses
por: Fagni, Filippo, et al.
Publicado: (2021)

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in patients with immunocompromising conditions: a review of available evidence
por: Chilson, Erica, et al.
Publicado: (2020)

Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV
por: Di Mario, Simona, et al.
Publicado: (2015)

A comprehensive analysis of the efficacy and safety of COVID-19 vaccines
por: Cai, Changjing, et al.
Publicado: (2021)

A review of the safety and efficacy of current COVID-19 vaccines
por: Huang, Zehong, et al.
Publicado: (2022)

COVID-19 vaccines: Considering sex differences in efficacy and safety
por: Jensen, Adelaide, et al.
Publicado: (2022)

Safety and efficacy of COVID-19 vaccines in people with neurological disorders
por: Wood, Heather
Publicado: (2021)

Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients
por: Kelly, Hannah, et al.
Publicado: (2021)

Assessing the long-term safety and efficacy of COVID-19 vaccines
por: Majeed, Azeem, et al.
Publicado: (2021)

COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
por: Fendler, Annika, et al.
Publicado: (2022)

Safety and Efficacy of the COVID-19 Vaccine in Kidney Transplant Recipients
por: Altheaby, Abdulrahman, et al.
Publicado: (2022)

35304 Safety and efficacy of COVID-19 vaccination in psoriasis patients
por: Baker, Mairead, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p2f6iuadsvn93t2jdvc3e5b0q7